Last reviewed · How we verify
NCT04571021: I-DEPT
Implementation of the Individual Danish Emergency Process Triage
NA trial testing I-DEPT in Acute Disease in 250,000 participants. Completed in 1 May 2022.
1 May 2022
Quick facts
| Lead sponsor | Herlev Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 250,000 |
| Start date | 1 October 2020 |
| Primary completion | 1 May 2022 |
| Estimated completion | 1 May 2022 |
| Sites | 8 locations across Denmark |
Drugs / interventions tested
- I-DEPT
- DEPT
Conditions studied
- Acute Disease — all drugs for Acute Disease →
- Emergencies — all drugs for Emergencies →
- Clinical Syndrome — all drugs for Clinical Syndrome →
Sponsor
Herlev Hospital
Who can join
Adults 17 to 110, any sex, with Acute Disease or Emergencies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to implement and evaluate a novel triage algorithm for risk stratification of acutely admitted patients in the Emergency Department.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04571021
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Disease
Currently open trials in the same condition.
- NCT06655337 — Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU) · NA · recruiting
- NCT06949228 — Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial · Phase 2, PHASE3 · recruiting
- NCT06901167 — Evaluation of a Residential In-Reach Program in Regional and Rural Australia · NA · recruiting
- NCT05913700 — Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study) · active not recruiting
- NCT04615065 — Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine · recruiting
Other Herlev Hospital trials
Trials by the same sponsor.
- NCT07367412 — Zinc Supplementation and Infections in Older Medical Patients · NA · not yet recruiting
- NCT07171216 — The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bon · NA · recruiting
- NCT07272187 — Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions · recruiting
- NCT07117955 — Platelet-Rich Plasma for Peyronie's Disease · NA · recruiting
- NCT07144046 — Tape Application Protocol for Enhanced Scars · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04571021 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Herlev Hospital
- Last refreshed: 3 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04571021.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing